Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X

Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X

US Patent 10087242 · Granted Oct 2, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protected tetrasaccharides, their process of preparation and their use as transg2023
Method of culturing segmented filamentous bacteria in vitro2023
Polyclonal antibodies specific for serogroup X of N. meningitidis and uses there2023
Polyclonal antibodies specific for serogroup x of N. meningitidis and uses there2020
Glycoconjugates and their use as potential vaccines against infection by Shigell2019
Glycoconjugates and their use as potential vaccines against infection by Shigell2019
Glycoconjugates and their use as potential vaccines against infection by Shigell2019
Glycoconjugates and their use as potential vaccines against infection by Shigell2019
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2018
Single cell based reporter assay to monitor gene expression patterns with high s2017
Glycoconjugates and their use as potential vaccines against infection by Shigell2016
Glycoconjugates and their use as potential vaccines against infection by Shigell2016